【北京】Zephyr AI，一家专注于开发快速且可解释的人工智能技术以推动精准医疗的初创公司，近日宣布成功完成了1.11亿美元的A轮融资。这一重大里程碑彰显了投资者对Zephyr AI在医疗技术领域的创新能力和市场潜力的高度认可。
本轮融资由知名投资机构Revolution Growth领投，医药巨头礼来公司、社会企业家Jeff Skoll以及EPIQ Capital Group等重量级投资者参与跟投。资金的注入将加速Zephyr AI的研发进程，推动其人工智能解决方案在精准医疗领域的广泛应用，帮助医生和医疗机构更准确地诊断和治疗疾病。
Zephyr AI的首席执行官表示：“我们非常荣幸得到这样一群有远见的投资者的支持。这笔资金将使我们能够加速研发，进一步优化我们的AI算法，以期在医疗保健领域实现更大的突破。我们的目标是通过可解释的人工智能，为每个患者提供个性化且精准的医疗方案。”
Zephyr AI的创新技术旨在解决医疗数据处理的复杂性，通过AI算法提高诊断效率和治疗效果，同时确保医疗决策的透明性和可理解性。随着这笔资金的到位，公司有望在精准医疗的道路上迈出更坚实的步伐，为全球医疗健康事业带来革命性的变化。
来源：BusinessWire
英语如下：
**News Title:** “Zephyr AI, a Precision Medicine Startup, Raises $110M in Series A Funding, Pioneering a New Era in AI-Driven Healthcare”
**Keywords:** Zephyr AI, Precision Medicine, Series A Funding
**News Content:**
**Title:** Zephyr AI Advances Precision Medicine with AI Algorithms, Secures $110M in Series A Financing
**Beijing** — Zephyr AI, a pioneering startup focused on developing explainable artificial intelligence (AI) technologies for precision medicine, has announced the successful closure of a $110 million Series A funding round. This significant milestone underscores investors’ confidence in Zephyr AI’s innovation and market potential within the medical technology sector.
The round was led by prominent investment firm Revolution Growth, with participation from pharmaceutical giant Eli Lilly, social entrepreneur Jeff Skoll, and EPIQ Capital Group, among other notable investors. The funds will accelerate Zephyr AI’s research and development efforts, propelling the broad application of its AI solutions in precision medicine and enabling healthcare professionals and institutions to diagnose and treat diseases more accurately.
Zephyr AI’s CEO commented, “We are thrilled to have the backing of such a visionary group of investors. This capital will enable us to accelerate our R&D, further refine our AI algorithms, and strive for groundbreaking advancements in healthcare. Our goal is to leverage explainable AI to deliver personalized and precise care for every patient.”
Zephyr AI’s innovative technology aims to address the complexity of managing medical data, enhancing diagnostic efficiency and treatment outcomes with AI algorithms while maintaining transparency and interpretability in medical decision-making. With this injection of funds, the company is poised to make more substantial strides in precision medicine, poised to bring transformative changes to global healthcare.
**Source:** BusinessWire
【来源】https://www.businesswire.com/news/home/20240312475536/en/Zephyr-AI-Raises-111-Million-in-Series-A-Financing
Views: 2